VVelarionINTELLIGENCE
Sign inStart free trial
Start free trial
MedTech & Diagnostics

KORU Medical Systems Executive Compensation (FY25)

KRMD · Executive and director compensation, fiscal 2022 to 2025
Chief executive, fiscal 2025
◇
Linda Tharby
Latest say-on-pay support
=
May 19, 2026
Velarion Member: every covered company in MedTech & Diagnostics, with dashboards, peer screens and board-ready briefs. Three seats, one year.

The KORU Medical Systems brief, $1,500

Positioning against its disclosed peers, the governance read, incentive design, and the CD&A alignment analysis; the full peer table; a committee-ready PDF.
Both reports for $2,400.
14 filings cited on this page
A report that fails to generate is refunded in full
Published by Velarion Company Intelligence
KORU Medical Systems brief$1,500Get the executive brief
Velarion Intel, one year, every company
163 figures on this page: 153 cited to the filing that reported them, 10 calculated from figures it prints. See the citations
What changed from fiscal 2024 to fiscal 2025
The figures that moved, and by how much. Analysis of these figures is part of the Velarion platform.
Chief executive total compensation — Linda Tharby: $1,271,525 → $1,737,883 (36.7% higher)
Say-on-pay support: 97.1% → 99.6% (2.5 points higher)

Frequently asked questions

Answers drawn from the data on this page.
Who is KORU Medical Systems' chief executive and what were they paid?
Linda Tharby was paid $1,737,883 in total compensation as Chief Executive Officer for fiscal 2025. Compared with the $1,271,525 reported for fiscal 2024, Tharby's total was 36.7% higher.
What was KORU Medical Systems' say-on-pay result?
Shareholders supported the say-on-pay proposal with 99.6% of votes cast for or against in favor at the meeting held May 19, 2026 for fiscal 2025.

Executive compensation

Every element reported for each named executive officer, by fiscal year.
Fiscal 2022
OfficerSalaryBonusStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
Brian Case
Chief Technology Officer
◇——◇◇—◇◇
Linda Tharby
President & CEO
◇———◇—◇◇
Thomas Adams
Chief Financial Officer
◇◇——◇—◇◇
Fiscal 2023
OfficerSalaryBonusStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
Kenneth Miller
Chief Commercial Officer
◇——◇◇—◇◇
Linda Tharby
President & CEO
◇———◇—◇◇
Thomas Adams
Chief Financial Officer
◇——◇◇—◇◇
Brian Case
Chief Technology Officer
◇———◇—◇◇
Fiscal 2024
OfficerSalaryBonusStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
Linda Tharby
President & CEO
◇—◇◇◇—◇◇
Brian Case
Former Chief Technology Officer
Departed during or after this year
◇———◇—◇◇
Thomas Adams
Chief Financial Officer
◇—◇◇◇—◇◇
Kenneth Miller
Chief Commercial Officer
◇—◇◇◇—◇◇
Fiscal 2025
OfficerSalaryBonusStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
Adam Kalbermatten
Chief Commercial Officer
◇—◇◇——◇◇
Linda Tharby
Chief Executive Officer
◇—◇◇◇—◇◇
Thomas Adams
Chief Financial Officer
◇—◇◇◇—◇— not reconciled
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero. A negative change in pension value is shown but, as the company reports it, not included in the total.

Equity awards granted

Individual awards as disclosed: type, date, unit counts at each level, and grant date value.
Fiscal 2025
OfficerAwardGrant dateThreshold unitsTarget unitsUnits grantedMaximum unitsExercise priceGrant date fair value
Adam KalbermattenOPTION◇——◇—◇◇
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero. Threshold, target and maximum apply only to performance awards and are never shown for time-based or option awards.

Outstanding awards

Awards still held at fiscal year end.
As disclosed at fiscal 2025 year end
OfficerAwardUnvested unitsMarket value of unvested unitsExercise priceExpires
Adam KalbermattenOption◇—◇8/1/2035
RSU◇◇——
Linda TharbyRSU◇◇——
PSU◇◇——
PSU◇◇——
Option◇—◇8/15/2034
Option◇—◇5/12/2035
Thomas AdamsPSU◇◇——
Option◇—◇5/12/2035
Option◇—◇7/30/2033
PSU◇◇——
Option◇—◇8/15/2034
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero.

Director compensation

What each non-employee director was paid.
Fiscal 2024
DirectorFees earned in cashStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
R. John Fletcher
Board chair
◇◇————◇
Robert A. Cascella
◇◇————◇
Joseph M. Manko Jr
◇◇————◇
Shahriar (Shar) Matin
◇◇————◇
Edward Wholihan
◇◇————◇
Donna French
◇◇————◇
Linda Tharby served on the board in fiscal 2024 and received no compensation for board service. Executive directors are typically paid through their executive roles, shown above.
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero.

Director fee schedule

The standing retainers and premiums the board pays, as published.
Board cash retainer◇
Board equity retainer◇
Total board retainer◇
Board chair premium◇
Audit committee chair◇
Compensation committee chair◇
Nominating and governance chair◇
Equity is delivered as Common Stock.

Disclosed peer group

The companies this board named as its compensation comparison group. The list is disclosure; the comparison is analysis.

Say-on-pay history

Shareholder support for the compensation program, by year.
YearMeetingSupportVotes forVotes againstAbstentions
2025May 19, 2026=◇◇◇
2024May 14, 2025=◇◇◇
2023May 9, 2024=◇◇◇
2022May 17, 2023=◇◇◇
2021May 6, 2022=◇◇◇
2020May 18, 2021=◇◇◇
2019April 22, 2020=◇◇◇
2018April 23, 2019=◇◇◇
2017April 23, 2018=◇◇◇
2015September 6, 2016=◇◇◇

Ask our research desk — $99, 24h, every figure cited to its filing.

Sample answer — “What is the CEO’s total compensation?”
- Linda Tharby (Chief Executive Officer), FY2025 total compensation $1,737,883 (base salary $596,960) [exec_comp, SEC accession 0001161697-26-000091, filed 2026-04-09]

See a complete sample report

Answered within 24 hours, every figure cited to its SEC filing. This is a one-off report: no refunds.

Email me this page as a cited PDF — sent in 2 minutes
The same figures, the same citations, formatted to hand to a committee. Nothing is added that is not on this page.
Your address is used for this and nothing else. Unsubscribe in one click.
Tell me when KORU Medical Systems files
You get a note when this company’s compensation data changes.
Your address is used for this and nothing else. Unsubscribe in one click.

What this page does not include

Everything above is a fact KORU Medical Systems disclosed, and it is free. Everything below is our analysis of those facts, and it is not.
Written compensation analysis
A read of the pay program as designed and as paid: incentive structure, goal rigor, the alignment between the committee's stated philosophy and what the numbers show.
Executive Compensation Report — $1,500
Board and governance analysis
Committee composition, independence, director pay positioning, and the governance provisions read together rather than listed.
Board Governance Report — $499
Realizable pay
What the awards above are actually worth today against what they were valued at on grant, and what the gap says about the pay-for-performance link.
Velarion Intelligence
Adviser switching and vote outcomes
Two datasets covering compensation-adviser changes and what followed a contested vote. Both are part of the Velarion platform.
Inquire about access
Multiple companies at once
Cross-company views, cohort screens, and data export across the industries we cover. This page is one company; the platform is all of them.
Velarion Intelligence
Join the list for Peer Group Review
Whether KORU Medical Systems' disclosed peer group is defensible, who names KORU Medical Systems back in their own benchmarking group, and how pay tracks performance across it. This is the analysis a compensation consultant delivers on the group above. We will email you when it opens.
Your address is used for this and nothing else. Unsubscribe in one click.

Citations

Every figure on this page is cited to the document that reported it. Select any figure to see its citation.
163 figures on this page: 153 cited to the filing that reported them, 10 calculated from figures it prints.
153 cited to the filing
10 calculated from the filing

Documents cited

  1. 0001161697-26-000128
    Item 5.07. Submission of Matters to a Vote of Security Holders.
  2. 0001161697-26-000091
  3. 0001161697-25-000173
    Item 5.07. Submission of Matters to a Vote of Security Holders.
  4. 0001161697-25-000139
  5. 0001161697-24-000230
    Item 5.07. Submission of Matters to a Vote of Security Holders.
  6. 0001161697-24-000162
  7. 0001161697-23-000302
    Item 5.07. Submission of Matters to a Vote of Security Holders.
  8. 0001161697-23-000194
  9. 0001161697-22-000232
    Item 5.07 SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS
  10. 0001161697-21-000276
    ITEM 5.07 SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS
  11. 0001161697-20-000164
    ITEM 5.07 SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS
  12. 0001161697-19-000153
    ITEM 5.07 SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS
  13. 0001161697-18-000218
    ITEM 5.07 SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS
  14. 0001161697-16-001070
    ITEM 5.07 SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS
Cite this data
This page is free to cite. Attribution we ask for:
Velarion, “KORU Medical Systems executive compensation, FY2022–FY2025.” https://intel.velarion.ai/comp/KRMD (accessed 2026).
Short form: data: Velarion

The KORU Medical Systems brief, $1,500

Positioning against its disclosed peers, the governance read, incentive design, and the CD&A alignment analysis; the full peer table; a committee-ready PDF.
Both reports for $2,400.
14 filings cited on this page
Method: intel.velarion.ai/methodology
A report that fails to generate is refunded in full
Published by Velarion Company Intelligence
Embed this data
A small, cited view of this data for your own page or newsletter. Every embed carries a visible link back here, so the attribution travels with it.
The headline figures, each with its citation.
Connect an AI assistant
Ask your own assistant about KORU Medical Systems and roughly 3,000 other US public companies, and get back the same figures on this page with the same citations. Free read access, no account. Add this to your assistant's connector settings.

MedTech & Diagnostics rankings

Terms on this page

Free to read and cite. Redistribution or bulk use of the dataset requires a data license. Talk to us about the data license.

Cite this data
APA
Velarion Company Intelligence. (2026). Velarion database: executive and board compensation data (Version 2026Q3) [Data set]. Zenodo. https://doi.org/10.5281/zenodo.22283854
BibTeX
@misc{velarionData2026,
  author = {{Velarion Company Intelligence}},
  title = {Velarion database: executive and board compensation data},
  year = {2026},
  version = {2026Q3},
  doi = {10.5281/zenodo.22283854},
  publisher = {Zenodo},
  url = {https://doi.org/10.5281/zenodo.22283854}
}
For informational purposes only. Not investment, legal, or compensation advice.  All companies · The Pay Desk · Methodology · Terms · Privacy